Sammamish, WA, United States of America

Michael E Houston, Jr

This inventor holds 18 USPTO granted patents and 16 published patent applications and 4 EPO patents, primarily in Nucleic Acid Delivery. Top assignees: Marina Biotech, Inc., Genevant Sciences Gmbh, Arcturus Therapeutics, Inc.. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael E Houston, Jr. Retrieved from https://idiyas.com/inventor/michael-e-houston-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 27.8

 

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 65(Granted Patents)


Location History:

  • Sammamish, WA (US) (2008 - 2018)
  • Kirkland, WA (US) (2018 - 2022)

Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Constructs
Lipopeptides
Block Copolymers
Therapeutics
Gene Expression
Amino Acid Lipids
Tyrosine-Based Lipids
Phage Display
RNA Delivery
Diagnostic Agents
Cellular Delivery
Conformationally Restricted Monomers
18 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I have processed your request. Here is the article about inventor Michael E Houston, Jr:

Title: Innovator Spotlight: Michael E Houston, Jr - Revolutionizing Biomedical Delivery Systems

Introduction: Michael E Houston, Jr. is an esteemed inventor based in Sammamish, WA, who has made significant contributions to the field of biomedical engineering. With a portfolio of 18 patents under his name, he continues to drive innovation in the development of advanced delivery systems for therapeutic and diagnostic agents.

Latest Patents: Among his latest patents is a groundbreaking invention focusing on methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells. This cutting-edge approach involves utilizing lipid nanoparticles containing the desired agents along with membrane-destabilizing polymers, enabling targeted delivery to the cytosol of cells.

Career Highlights: Michael E Houston, Jr. has demonstrated his expertise through collaborations with leading companies in the industry. Notable among them are Marina Biotech, Inc. and Genevant Sciences Gmbh, where he has played a pivotal role in shaping the future of biomedical technologies.

Collaborations: Throughout his career, Michael E Houston, Jr. has worked closely with accomplished professionals such as Pierrot Harvie and Mary Gallagher Prieve. These collaborations have led to the development of innovative solutions that have the potential to revolutionize the field of biomedical engineering.

Conclusion: In conclusion, Michael E Houston, Jr. stands out as a visionary inventor whose dedication to advancing biomedical delivery systems is reshaping the landscape of modern medicine. With a proven track record of success and a passion for innovation, he continues to inspire others in the industry to push the boundaries of what is possible in the world of healthcare.

If you require further information or have any specific requests, feel free to let me know.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…